JP2018506554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018506554A5 JP2018506554A5 JP2017544867A JP2017544867A JP2018506554A5 JP 2018506554 A5 JP2018506554 A5 JP 2018506554A5 JP 2017544867 A JP2017544867 A JP 2017544867A JP 2017544867 A JP2017544867 A JP 2017544867A JP 2018506554 A5 JP2018506554 A5 JP 2018506554A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- less
- water
- particles
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 claims 14
- 239000002245 particle Substances 0.000 claims 9
- 239000002105 nanoparticle Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims 2
- 229940086555 cyclomethicone Drugs 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000003961 penetration enhancing agent Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000080 wetting agent Substances 0.000 claims 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 1
- WTJXVDPDEQKTCV-UHFFFAOYSA-N 4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydron;chloride Chemical group Cl.C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2C1CC1C(N(C)C)C(=O)C(C(N)=O)=C(O)C1(O)C2=O WTJXVDPDEQKTCV-UHFFFAOYSA-N 0.000 claims 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010021531 Impetigo Diseases 0.000 claims 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 229940008099 dimethicone Drugs 0.000 claims 1
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 1
- 239000003349 gelling agent Substances 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 229960004023 minocycline Drugs 0.000 claims 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical group C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 claims 1
- 229960002421 minocycline hydrochloride Drugs 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
Claims (8)
- i.粒子の90%が1000nm未満であるような粒度分布を有する、水溶性水感受性有効成分またはその薬学的に許容される塩のナノ粒子と、
ii.1種以上の湿潤剤と、
iii.少なくとも1種のゲル化剤と、
iv.非水性液体ビヒクルと、
を含むナノ粒子局所組成物であって、
ここで、該組成物は水を含まず、
前記水溶性水感受性有効成分は、ミノサイクリンまたはその薬学的に許容される塩であり、
前記1種以上の湿潤剤は、シクロメチコン−ジメチコンコポリオールポリマーであり、
前記非水性液体ビヒクルは、シクロメチコンまたはシクロメチコンと鉱油の混合物を含み、
さらに、前記局所組成物が、ゲルである、組成物。 - 前記ナノ粒子が、粒子の90%(D90)が1000nm未満であり、前記粒子の50%(D50)が800nm未満であるような粒度分布を有する、請求項1に記載の組成物。
- 前記ナノ粒子が、粒子の90%(D90)が700nm未満であり、前記粒子の50%(D50)が500nm未満であり、前記粒子の10%(D10)が300nm未満であるような粒度分布を有する、請求項1に記載の組成物。
- 前記水溶性水感受性有効成分がミノサイクリン塩酸塩であり、約0.01%w/w〜約15%w/wに及ぶ濃度で組成物中に存在する、請求項1に記載の組成物。
- 前記湿潤剤が前記組成物の約0.5重量%〜20.0重量%に及ぶ濃度で存在する、請求項1に記載の組成物。
- 浸透促進剤をさらに含む、請求項1に記載の組成物。
- 前記浸透促進剤がミリスチン酸イソプロピルまたはオレイン酸から選択される、請求項6に記載の組成物。
- ざ瘡、酒さ、膿痂疹、または細菌によって引き起こされる皮膚疾患の治療用の、局所施用による、請求項1に記載のナノ粒子局所組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN623/MUM/2015 | 2015-02-25 | ||
IN623MU2015 | 2015-02-25 | ||
PCT/IN2016/050068 WO2016135754A1 (en) | 2015-02-25 | 2016-02-25 | Nanoparticulate composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018506554A JP2018506554A (ja) | 2018-03-08 |
JP2018506554A5 true JP2018506554A5 (ja) | 2019-05-16 |
Family
ID=56789380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017544867A Ceased JP2018506554A (ja) | 2015-02-25 | 2016-02-25 | ナノ粒子組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10512608B2 (ja) |
EP (1) | EP3261619A4 (ja) |
JP (1) | JP2018506554A (ja) |
AU (1) | AU2016224863A1 (ja) |
CA (1) | CA2977612A1 (ja) |
WO (1) | WO2016135754A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5122519A (en) | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
US8236352B2 (en) * | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US20040115134A1 (en) | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
AU2002239504A1 (en) * | 2000-12-06 | 2002-06-18 | Pharmacia Corporation | Laboratory scale milling process |
US20080220075A1 (en) | 2002-03-20 | 2008-09-11 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
EP1551457A1 (en) * | 2002-07-16 | 2005-07-13 | Elan Pharma International Limited | Liquid dosage compositions of stable nanoparticulate active agents |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20160158261A1 (en) | 2002-10-25 | 2016-06-09 | Foamix Pharmaceuticals Ltd. | Antibiotic Kit and Composition and Uses Thereof |
GB0403702D0 (en) | 2004-02-19 | 2004-03-24 | Boots Co Plc | Skincare compositions |
WO2012050591A1 (en) | 2010-10-15 | 2012-04-19 | Rutgers, The State University Of New Jersey | Hydrogel formulation for dermal and ocular delivery |
US8920821B2 (en) * | 2006-04-14 | 2014-12-30 | Perrigo Israel Pharmaceuticals Ltd. | Pharmaceutical compositions comprising silica microspheres |
WO2008097850A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
US20080188446A1 (en) * | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
CN105147608B (zh) | 2008-06-26 | 2019-12-10 | 安特里奥公司 | 真皮递送 |
US8784852B2 (en) | 2009-02-27 | 2014-07-22 | Audrey Kunin | Topical skin care composition |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
MX359879B (es) * | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Composiciones tópicas de tetraciclina. |
SG10201600332TA (en) | 2011-01-19 | 2016-02-26 | Lab Skin Care Inc | Topical minocycline compositions and methods of using the same |
PT106679B (pt) * | 2012-11-27 | 2015-03-25 | Hovione Farmaciencia Sa | Formulações tópicas de tetraciclinas, sua preparação e usos |
IN2013MU03646A (ja) | 2013-11-20 | 2015-07-31 | Lupin Ltd | |
BR112016017690A2 (pt) | 2014-01-29 | 2017-08-08 | Vyome Biosciences Pvt Ltd | Tratamentos para acne resistente |
-
2016
- 2016-02-25 JP JP2017544867A patent/JP2018506554A/ja not_active Ceased
- 2016-02-25 EP EP16754875.9A patent/EP3261619A4/en not_active Withdrawn
- 2016-02-25 WO PCT/IN2016/050068 patent/WO2016135754A1/en active Application Filing
- 2016-02-25 US US15/552,966 patent/US10512608B2/en not_active Expired - Fee Related
- 2016-02-25 AU AU2016224863A patent/AU2016224863A1/en not_active Abandoned
- 2016-02-25 CA CA2977612A patent/CA2977612A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018506554A5 (ja) | ||
Abd-Elsalam et al. | Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery | |
KR100990810B1 (ko) | 안과용 약물 및 이과용 약물을 위한 담체로서 합성 무기 나노입자의 용도 | |
JP2013513612A5 (ja) | ||
Cunha et al. | Delivery system for mefenamic acid based on the nanocarrier layered double hydroxide: Physicochemical characterization and evaluation of anti-inflammatory and antinociceptive potential | |
US11919770B2 (en) | Nano-sulfur containing composition and application thereof | |
ES2815571T3 (es) | Composiciones de silicato estabilizado y su uso como composiciones antitranspirantes | |
JP2009280627A5 (ja) | ||
JP5740393B2 (ja) | 皮膚および爪の真菌感染症の局所治療に適した組成物 | |
EP2124878A1 (en) | Increased effectiveness of allylamine drug compounds | |
BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
CN103655459A (zh) | 一种多功能微乳凝胶制剂及其制备工艺 | |
JP2015502403A (ja) | オーラル・ケア組成物 | |
Ranneh et al. | The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles | |
Dong et al. | Clay as a matrix former for spray drying of drug nanosuspensions | |
JP2006526026A (ja) | 風邪及びインフルエンザ様症状の予防及び治療のためのキレート化亜鉛を含む組成物 | |
Iannuccelli et al. | Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection | |
US20220142914A1 (en) | Suspension formulations of high load dispersions | |
TW201236697A (en) | Oral and personal care compositions | |
JP2014534215A5 (ja) | ||
WO2017024953A1 (zh) | 尼莫地平水溶性衍生物及其制备方法和应用 | |
CN107249574A (zh) | 水凝胶组合物、其制备方法及其应用 | |
MY150820A (en) | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance | |
WO2010023908A1 (ja) | インドメタシン含有ナノカプセルおよびその製造方法 | |
WO2015118885A1 (ja) | 細菌性皮膚病用殺菌組成物 |